Studies on isolation, serum-free cultivation and manufacture of mink enteritis virus optimized for vaccine

D L Zhang1

  • 1Chinese Army Laboratory of Molecular Virology & Genetic Engineering, Institute of Preventive Medicine & Veterinary Science in Beijing Military Area of Chinese PLA, Fengtai District, P.R. China.

Insights

Optimum growth conditions were identified for mink enteritis virus (MEV) in feline kidney cell (FKC) lines. Strains S18 and L12 are recommended for mink viral enteritis (MVE) vaccine development due to high viral titers and immunogenicity.

Area of Science:

  • Veterinary Virology
  • Cell Culture Technology

Background:

  • Mink viral enteritis (MVE) is a significant disease affecting mink populations.
  • Effective vaccine development requires optimizing virus propagation and identifying virulent strains.

Purpose of the Study:

  • To determine optimal conditions for growing mink enteritis virus (MEV) in feline kidney cell (FKC) lines.
  • To evaluate MEV strains for vaccine preparation and challenge testing.

Main Methods:

  • Cultivation of MEV strains (S18, S36, L12) in FKC lines under various conditions.
  • Measurement of viral growth using hemagglutination (HA) units and 50% tissue culture infectious dose (TCID50).
  • Isolation of MEV from intestinal mucosal cylinders of infected mink.

Main Results:

  • MEV strains S18 and S36 achieved high titers (8192-32,786 HA units or 10(-9.7-10.3) TCID50) in FKC lines.
  • MEV strain L12, isolated from infected mink, replicated to high titers (8192 HA units or 10(9.7) TCID50).
  • An inactivated virus vaccine using these strains induced a robust immune response in mink.

Conclusions:

  • Strains S18 and L12 of MEV are suitable for inactivated vaccine production.
  • Strain L12 is identified as the most virulent strain for challenge tests in vaccine efficacy studies.